Biofrontera (AI10) Income Statement
Biofrontera Income Statement
Last quarter (Q2 2026), Biofrontera's total revenue was $12.00M, an increase of 32.92% from the same quarter last year. In Q2, Biofrontera's net income was $-604.00K. See Biofrontera’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| $ 41.70M | $ 37.30M | $ 34.07M | $ 28.67M | $ 24.10M | |
| $ 32.80M | $ 18.70M | $ 16.63M | $ 13.49M | $ 11.36M | |
| $ 41.95M | $ 35.92M | $ 39.30M | $ 32.07M | $ 36.56M | |
| Depreciation and Amortization | $ 868.00K | $ 1.15M | $ 1.06M | $ 1.17M | $ 540.00K |
| $ -9.19M | $ -14.44M | $ -18.45M | $ 934.00K | $ -36.76M | |
| $ -9.15M | $ -17.21M | $ -22.68M | $ -18.58M | $ -25.20M | |
| $ -1.36M | $ -527.00K | $ 2.56M | $ 17.97M | $ -12.46M | |
| $ -10.51M | $ -17.74M | $ -20.12M | $ -608.00K | $ -37.66M | |
| $ -10.54M | $ -17.76M | $ -20.13M | $ -640.00K | $ -37.71M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.04 | $ -3.22 | $ -13.02 | $ -0.61 | $ -44.10 |
| Diluted EPS | $ -0.90 | $ -3.22 | $ -13.02 | $ -0.61 | $ -44.10 |
| Weighted Average Shares Outstanding | 10.17M | 5.52M | 1.55M | 1.06M | 855.24K |
| Weighted Average Shares Outstanding (Diluted) | 11.65M | 5.52M | 1.55M | 1.06M | 855.24K |
Currency in USD
